Home » NTrans Technologies closes Series A investment to accelerate development of gene editing therapy. » Press Release NTrans investment v20210527

Press Release NTrans investment v20210527

Press Release NTrans investment v20210527

New therapies for the treatment of genetic diseases and cancer

Contact us

info@ntranstechnologies.com